サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439246

冠動脈ステント - 世界市場の考察、競合情勢、市場予測（2030年）

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
冠動脈ステント - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の冠動脈ステントの市場規模は、2023年に92億7,000万米ドル、2030年までに142億8,000万米ドルに達し、2024年～2030年の予測期間にCAGRで7.51％の成長が見込まれます。冠動脈ステント需要の増加は、主に老年人口の増加による脳卒中、アテローム性動脈硬化症、心臓発作などの心血管障害の有病率の上昇、PCI（経皮的冠動脈インターベンション）手技件数の増加、低侵襲手術の需要の増加、製品ラインの技術の進歩などに起因しています。

冠動脈ステントの市場力学

冠動脈ステント市場の成長に影響を与える主な要因の1つは、世界中でさまざまな心血管疾患の有病率が増加していることです。例えば、米国心臓協会（American Heart Association）（2022）によると、2020年に全世界で約2億4,410万人が冠動脈（虚血）性心疾患を患っています。

英国心臓財団が提供したデータ（2022）によると、2019年も冠動脈性心疾患は、世界中に約2億人の患者がいる、世界でもっとも流行している心血管系の疾患の1つでした。

高齢、肥満、喫煙など、何らかの形で心血管疾患の開発を引き起こす危険因子の増加は、冠動脈ステントの市場成長をさらに促進しています。例えば、WHOが提供したデータ（2023）によると、2020年に世界中の60歳以上の人口は約10億人でした。60歳以上の老年人口は2050年までに倍増し、約21億人に達すると予測されています。

このように、上記の疾患による有病率や死亡率の増加は、冠動脈ステントを用いた適切な治療を行うことで管理または減少させることができ、その結果、この装置に対する需要の増加につながります。したがって、前述の要因が今後数年間における冠動脈ステント市場全体を押し上げる見込みです。

製品リコールの増加や厳しい規制承認プロセスなどの特定の要因が、冠動脈ステント市場の成長に小さな障害をもたらす可能性があります。

冠動脈ステント市場のセグメント分析

冠動脈ステント製品セグメントでは、予測期間に薬剤溶出性ステントが最大の市場シェアを占めると予測されます。これは、ベアメタルステントなどに対する薬剤溶出性ステントのさまざまな利点によるものです。

薬剤溶出性ステントはベアメタルステントを使用するよりも再狭窄の予防に効果的であり、新世代の薬剤溶出性ステントを使用することでステント血栓症や心筋梗塞の罹患率も低下します。例えば、研究によると、比較的リスクの低い患者人口における5年後のステント血栓症の罹患率は0.5％でした。

さらに、近年の製品承認も薬剤溶出性冠動脈ステント市場をさらに押し上げると予測されています。例えば、2020年にSCITECH Medicalが第3世代の薬剤溶出性ステントであるINSPIRON Coronary Sirolimus Eluting StentのCEマーク承認を取得しました。

したがって、前述の要因は冠動脈ステント市場のセグメント別成長を促進する可能性が高いです。

北米が冠動脈ステント市場全体を独占すると予測されます。

すべての国の中で、北米が予測期間に冠動脈ステント市場全体を独占すると予測されます。この優位性は、冠動脈性心疾患やその他のCVDの有病率の上昇、医療インフラの改善、有利な償還シナリオなどによるものです。

米国疾病予防管理センター（CDC）（2022）は、2020年に米国で20歳以上の成人約2,010万人が冠動脈疾患（CAD）に罹患すると推定しています。また、同じ資料によると、米国では40秒に1人が心臓発作を起こしています。毎年、米国では約80万5,000人が心臓発作を起こしています。このうち60万5,000人は初めての心臓発作で、20万人はすでに心臓発作を起こしたことがある人々です。

当レポートでは、世界の冠動脈ステント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 冠動脈ステント市場レポートのイントロダクション

第2章 冠動脈ステント市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 冠動脈ステント市場の主な要因の分析

  • 冠動脈ステント市場の促進要因
    • 心血管障害（CVD）の有病率の上昇
    • PCI（経皮的冠動脈インターベンション）手技件数の増加
    • 低侵襲手術の需要の増加
    • 技術の進歩
  • 冠動脈ステント市場の抑制要因と課題
    • 製品リコール
    • 厳格な規制当局の承認
  • 冠動脈ステント市場の機会
    • 生体吸収性血管スキャフォールド（足場材）へのシフト
    • 新興国における成長機会

第5章 冠動脈ステントのポーターのファイブフォース分析

第6章 冠動脈ステント市場のレイアウト

  • 製品タイプ別
    • ベアメタルステント
    • 薬剤溶出性ステント
    • 薬剤コーティングステント
  • 材料別
    • 金属
    • ポリマー
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • その他
  • 地域別
    • 北米の冠動脈ステントの市場規模（2021年～2030年）
    • 欧州の冠動脈ステントの市場規模（2021年～2030年）
    • アジア太平洋の冠動脈ステントの市場規模（2021年～2030年）
    • その他の地域の冠動脈ステントの市場規模（2021年～2030年）

第7章 冠動脈ステントの企業と製品のプロファイル

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Biosensors International Group, Ltd.
  • BIOTRONIK
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts
  • COOK
  • SCITECH Medical
  • Lepu Medical Technology Co., Ltd.
  • OrbusNeich Medical Company Limited

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Coronary Stents Market in Global (2021-2030)
  • Table 3: Coronary Stents Market in Global by Product Type (2021-2030)
  • Table 4: Coronary Stents Market in Global by Material (2021-2030)
  • Table 5: Coronary Stents Market in Global by End-User (2021-2030)
  • Table 6: Coronary Stents Market in Global by Geography (2021-2030)
  • Table 7: Coronary Stents Market in North America (2021-2030)
  • Table 8: Coronary Stents Market in the US (2021-2030)
  • Table 9: Coronary Stents Market in Canada (2021-2030)
  • Table 10: Coronary Stents Market in Mexico (2021-2030)
  • Table 11: Coronary Stents Market in Europe (2021-2030)
  • Table 12: Coronary Stents Market in France (2021-2030)
  • Table 13: Coronary Stents Market in Germany (2021-2030)
  • Table 14: Coronary Stents Market in the United Kingdom (2021-2030)
  • Table 15: Coronary Stents Market in Italy (2021-2030)
  • Table 16: Coronary Stents Market in Spain (2021-2030)
  • Table 17: Coronary Stents Market in Rest of Europe (2021-2030)
  • Table 18: Coronary Stents Market in Asia-Pacific (2021-2030)
  • Table 19: Coronary Stents Market in China (2021-2030)
  • Table 20: Coronary Stents Market in Japan (2021-2030)
  • Table 21: Coronary Stents Market in India (2021-2030)
  • Table 22: Coronary Stents Market in Australia (2021-2030)
  • Table 23: Coronary Stents Market in South Korea (2021-2030)
  • Table 24: Coronary Stents Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Coronary Stents Market in the Rest of the World (2021-2030)
  • Table 26: Coronary Stents Market in the Middle East (2021-2030)
  • Table 27: Coronary Stents Market in Africa (2021-2030)
  • Table 28: Coronary Stents Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Coronary Stents Market in Global (2021-2030)
  • Figure 3: Coronary Stents Market in Global by Product Type (2021-2030)
  • Figure 4: Coronary Stents Market in Global by Material (2021-2030)
  • Figure 5: Coronary Stents Market in Global by End-User (2021-2030)
  • Figure 6: Coronary Stents Market in Global by Geography (2021-2030)
  • Figure 7: Coronary Stents Market in North America (2021-2030)
  • Figure 8: Coronary Stents Market in the US (2021-2030)
  • Figure 9: Coronary Stents Market in Canada (2021-2030)
  • Figure 10: Coronary Stents Market in Mexico (2021-2030)
  • Figure 11: Coronary Stents Market in Europe (2021-2030)
  • Figure 12: Coronary Stents Market in France (2021-2030)
  • Figure 13: Coronary Stents Market in Germany (2021-2030)
  • Figure 14: Coronary Stents Market in the United Kingdom (2021-2030)
  • Figure 15: Coronary Stents Market in Italy (2021-2030)
  • Figure 16: Coronary Stents Market in Spain (2021-2030)
  • Figure 17: Coronary Stents Market in Rest of Europe (2021-2030)
  • Figure 18: Coronary Stents Market in Asia-Pacific (2021-2030)
  • Figure 19: Coronary Stents Market in China (2021-2030)
  • Figure 20: Coronary Stents Market in Japan (2021-2030)
  • Figure 11: Coronary Stents Market in India (2021-2030)
  • Figure 22: Coronary Stents Market in Australia (2021-2030)
  • Figure 23: Coronary Stents Market in South Korea (2021-2030)
  • Figure 24: Coronary Stents Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 25: Coronary Stents Market in the Rest of the World (2021-2030)
  • Figure 26: Coronary Stents Market in the Middle East (2021-2030)
  • Figure 27: Coronary Stents Market in Africa (2021-2030)
  • Figure 28: Coronary Stents Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0033

The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030. The rise in demand for coronary stents is primarily attributed to the rising prevalence of cardiovascular disorders such as stroke, atherosclerosis, and heart attack due to the increasing geriatric population; a growing number of PCI (Percutaneous Coronary Intervention) procedures; increase in demand for minimally invasive surgeries, and technological advancement in the product line, among others.

Coronary Stents Market Dynamics:

One of the key factors influencing the growth of the coronary stents market is the increasing prevalence of various cardiovascular diseases across the globe. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, in 2019 coronary heart disease remained one of the most prevalent cardiovascular conditions worldwide accounting for about 200 million cases globally.

The increasing number of risk factors such as old age, obesity, smoking, and others causing the development of cardiovascular diseases in one or another way are further driving the market growth for coronary stents. For instance, according to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050.

Thus, the increasing prevalence and mortality rate from the above-mentioned disorders can be either managed or reduced by providing proper treatment using coronary stents, thereby leading to an increased demand for the device. Therefore, the afore-said factor will propel the overall market of coronary stents in the upcoming years.

Certain factors such as increasing product recalls, and stringent regulatory approval processes may pose a minor hurdle to the growth of the coronary stents market.

Coronary Stents Market Segment Analysis:

Coronary Stents By Product Type (Bare Metal Stents, Drug Eluting Stents, and Drug-Coated Stents), Material (Metals [Stainless Steel, Cobalt-Chromium (CoCr), Platinum-Chromium (PtCr), and Nitinol] and Polymers), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Coronary Stents product segment, the drug-eluting stent is expected to hold the largest market share during the forecast period. This is due to the various advantages of drug-eluting stents over bare metal stents and others.

Drug-eluting stents are more effective in the prevention of restenosis than the use of bare-metal stents, the use of newer-generation drug-eluting stents also reduces the rate of stent thrombosis and myocardial infarction. For instance, as per research studies, there was a 0.5% rate of stent thrombosis at 5 years among a relatively low-risk population of patients.

Moreover, recent product approval is also anticipated to further boost the market the drug-eluting coronary stent market. For instance, in 2020, SCITECH Medical received CE Mark approval for its third-generation drug-eluting stent, INSPIRON Coronary Sirolimus Eluting Stent.

Therefore, the aforementioned factors are likely to propel the segmental growth of the coronary stents market.

North America is expected to dominate the overall Coronary Stents Market:

Among all the countries, North America is expected to dominate the overall coronary stents market during the forecast period. This domination is due to the rising prevalence of coronary heart diseases and other CVDs, improved healthcare infrastructure, and favorable reimbursement scenarios in the region among others.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020. Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

In addition, the presence of key manufacturers such as Medtronic, and Boston Scientific Corporation, among others is also likely to boost the coronary stents market. Furthermore, recent product approval in the region will also contribute to the market growth. For instance, in 2019, German medical device company Biotronik received US Food and Drug Administration (FDA) approval for Orsiro drug-eluting coronary stent (DES) system.

Hence, the above-mentioned factors are contributing in regional market growth during the forecast period.

Coronary Stents Market Key Players:

Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

Coronary Stents Market Recent Developmental Activities:

In August 2020, Boston Scientific Corporation received FDA approval for its SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire).

In October 2020, Biosensors received the CE Mark for BioFreedomUltra, a new drug-coated coronary stent system with a thin strut (84µm) CoCr polymer and Biosensors' Biolimus A9 drug.

Key Takes Away from the Coronary Stents Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global coronary stents market.

Various opportunities available for the other competitor in the coronary stents market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for coronary stents market growth in the coming future?

Target Audience who can be benefited from Coronary Stents Market Report Study

Coronary Stents providers

Research organizations and consulting companies

Coronary Stents-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Coronary Stents

Various End-Users who want to know more about the coronary stents market and the latest technological developments in the coronary stents market.

Frequently Asked Questions for Coronary Stents Market:

1. What are Coronary Stents?

Coronary stents are small, expandable, wired mesh tubes that help in the widening of a clogged artery and restore adequate blood flow to the heart. These stents are predominantly of two categories bare metal and drug-eluting.

2. What is the market for global coronary stents?

The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030.

3. What are the drivers for global coronary stents?

The major drivers driving the demand for coronary stents are the growing burden of the old age population susceptible to various cardiovascular disorders, shifting preferences towards minimally invasive surgeries, and technological advancement in the product line, among others.

4. Who are the key players operating in global coronary stents?

Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.

5. Which region has the highest share in the coronary stents market?

North America is anticipated to dominate the overall coronary stents market during the forecast period, 2024-2030 due to the improved healthcare infrastructure, and favorable reimbursement scenario in the region. Moreover, recent product approvals and the presence of key manufacturers are also factors contributing to the highest market share.

Table of Contents

1. Coronary Stents Market Report Introduction

2. Coronary Stents Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Coronary Stents Market Key Factors Analysis

  • 4.1. Coronary Stents Market Drivers
    • 4.1.1. Rising prevalence of cardiovascular disorders (CVDs)
    • 4.1.2. Growing number of PCI (Percutaneous Coronary Intervention) procedures
    • 4.1.3. Increasing demand for minimally invasive surgeries
    • 4.1.4. Technological advancements
  • 4.2. Coronary Stents Market Restraints and Challenges
    • 4.2.1. Product recalls
    • 4.2.2. Stringent regulatory approvals
  • 4.3. Coronary Stents Market Opportunities
    • 4.3.1. Shift toward bioresorbable vascular scaffolds
    • 4.3.2. Growth opportunities in emerging countries

5. Coronary Stents Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Coronary Stents Market layout

  • 6.1. By Product Type
    • 6.1.1. Bare Metal Stents
    • 6.1.2. Drug Eluting Stents
    • 6.1.3. Drug-Coated Stents
  • 6.2. By Material
    • 6.2.1. Metals
      • 6.2.1.1. Stainless Steel
      • 6.2.1.2. Cobalt-Chromium (CoCr)
      • 6.2.1.3. Platinum-Chromium (PtCr)
      • 6.2.1.4. Nitinol
    • 6.2.2. Polymers
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.2. Europe Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.1. France Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.1. China Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.3. India Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia Pacific Coronary Stents Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Coronary Stents Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Coronary Stents Market Size in USD million (2021-2030)

7. Coronary Stents Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Abbott
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Biosensors International Group, Ltd.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. BIOTRONIK
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. B. Braun Melsungen AG
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Terumo Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. STENTYS SA
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. MicroPort Scientific Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Meril Life Sciences Pvt. Ltd.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Vascular Concepts
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. COOK
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. SCITECH Medical
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Lepu Medical Technology Co., Ltd.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. OrbusNeich Medical Company Limited
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us